(Q43441417)

23 November 2017

Patterns of antidepressant medication use among pregnant women in a United States population (English)

1 reference

23 November 2017

United States of America

0 references

1 reference

1 reference

4

1 reference

23 November 2017

3

Sonja A Rasmussen

0 references

Jennita Reefhuis

series ordinal

2

object named as

Jennita Reefhuis

1 reference

PubMed ID

20663997

National Birth Defects Prevention Study

23 November 2017

series ordinal

5

object named as

National Birth Defects Prevention Study

1 reference

23 November 2017

Sura Alwan

1

1 reference

23 November 2017

27 July 2010

1 reference

The Journal of Clinical Pharmacology

23 November 2017

1 reference

23 November 2017

51

1 reference

23 November 2017

264-270

1 reference

23 November 2017

2

1 reference

Pharmacologic treatment of depression during pregnancy

23 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Clinically identified maternal depression before, during, and after pregnancies ending in live births

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

The medical management of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Neonate characteristics after maternal use of antidepressants in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

The National Birth Defects Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Use of antidepressant medications during pregnancy: a multisite study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Recent trends in selective serotonin reuptake inhibitor use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Prevalence and predictors of antidepressant use in a cohort of pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Prevalence and patterns of antidepressant drug use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Prenatal depression effects on the fetus and newborn: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Safety of selective serotonin reuptake inhibitors in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010373928

21 January 2018

Identifiers

DOI

10.1177/0091270010373928

1 reference

23 November 2017

1 reference

PubMed ID

20663997